Early Access to Medicines Scheme: real-world data collection

被引：3

作者：

Pang, Hok ^{[1
]}

Wang, Meng ^{[1
]}

Kiff, Christopher ^{[1
]}

Soni, Mira ^{[2
]}

Stein, Dara ^{[2
]}

Tyas, David ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Ltd, London, England

[2] Evidera, London, England

来源：

DRUG DISCOVERY TODAY | 2019年 / 24卷 / 12期

关键词：

D O I：

10.1016/j.drudis.2019.06.009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Real-world data (RWD) generated during the pre-approval phase could be supplementary to primary clinical trial outcomes; however, as we discuss here, a data collection framework is needed to ensure the validity and applicability of these data.

引用

页码：2231 / 2233

页数：3

共 50 条

[41] Strategies to Turn Real-world Data Into Real-world Knowledge
Hong, Julian C.
JAMA NETWORK OPEN, 2021, 4 (10)
[42] Deriving Real-World Insights From Real-World Data
Baker, Stuart G.
ANNALS OF INTERNAL MEDICINE, 2019, 170 (09) : 664 - 665
[43] Automating access to real-world evidence
Gauthier, M-P.
Law, J. H.
Le, L.
Zahir, S.
Li, J.
Sung, M.
Chu, R.
Leighl, N.
ANNALS OF ONCOLOGY, 2020, 31 : S879 - S880
[44] Automating Access to Real-World Evidence
Gauthier, Marie-Pier
Law, Jennifer H.
Le, Lisa W.
Li, Janice J. N.
Zahir, Sajda
Nirmalakumar, Sharon
Sung, Mike
Pettengell, Christopher
Aviv, Steven
Chu, Ryan
Sacher, Adrian
Liu, Geoffrey
Bradbury, Penelope
Shepherd, Frances A.
Leighl, Natasha B.
JTO CLINICAL AND RESEARCH REPORTS, 2023, 3 (06):
[45] Engineering ontology-based access to real-world data sources
Skjaeveland, Martin G.
Giese, Martin
Hovland, Dag
Lian, Espen H.
Waaler, Arild
JOURNAL OF WEB SEMANTICS, 2015, 33 : 112 - 140
[46] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
Richard E. Gliklich
Michelle B. Leavy
Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
[47] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
Gliklich, Richard E.
Leavy, Michelle B.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
[48] Artificial Intelligence, Real-World Automation and the Safety of Medicines
Andrew Bate
Steve F. Hobbiger
Drug Safety, 2021, 44 : 125 - 132
[49] The use of real-world evidence in European medicines regulation
Brown, Jeremy P.
Wing, Kevin
Evans, Stephen
Bhaskaran, Krishnan
Smeeth, Liam
Douglas, Ian
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 205 - 206
[50] Editorial: Real-world data and real-world evidence in lung cancer
Gristina, Valerio
Eze, Chukwuka
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →